Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan Dual vs Bismuth Quadruple Therapy for H. pylori Rescue
NCT06168084Phase 4Completed
- Sponsor
- Yongquan Shi
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Yongquan Shi. Started Jun 2023; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06168084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168084.